ImmunoPrecise Antibodies Employees

As of April 30, 2024, ImmunoPrecise Antibodies had 101 total employees, including 72 full-time and 29 part-time employees. The number of employees decreased by 1 or -0.98% compared to the previous year.

Employees

101

Change (1Y)

-1

Growth (1Y)

-0.98%

Revenue / Employee

$172,692

Profits / Employee

-$198,976

Market Cap

11.13M

Employees Chart

Employees History

Date	Employees	Change	Growth
Apr 30, 2024	101	-1	-0.98%
Apr 30, 2023	102	17	20.00%
Apr 30, 2022	85	12	16.44%
Apr 30, 2021	73	-	-

Related Stocks

Company Name	Employees
China Jo-Jo Drugstores	1,003
Trinity Biotech	380
MSP Recovery	88
Aspira Women's Health	64
Sol-Gel Technologies	36
Sensei Biotherapeutics	28
AIM ImmunoTech	28
Talphera	15

Employee Rankings

IPA News

8 days ago - $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies - Business Wire
17 days ago - ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - Business Wire
24 days ago - ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire
4 weeks ago - ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - Business Wire
5 weeks ago - Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District - Business Wire
6 weeks ago - ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design - Business Wire
7 weeks ago - ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus - Business Wire
2 months ago - ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments - Business Wire

More News